Published Studies Related to Pepcid Injection (Famotidine Injection)
Well-designed clinical trials related to Pepcid Injection (Famotidine Injection)
Esomeprazole Compared With Famotidine in the Prevention of Upper Gastrointestinal Bleeding in Patients With Acute Coronary Syndrome or Myocardial Infarction. [2011.11.22]
Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. [2011.07]
Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. [2011.03]
Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs. [2011.01]
A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis. [2010.12]
Efficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs. [2010.03]
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. [2010.01]
A double-blind, controlled study comparing lafutidine with placebo and famotidine
in Japanese patients with mild reflux esophagitis. [2010]
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. [2009.07.11]
Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH. [2009.03]
Can famotidine and omeprazole be combined on a once-daily basis? [2007.06]
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers. [2007.02]
The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: A non-inferiority trial. [2007.01]
Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE-famotidine or rebamipide in comparison by endoscopy). [2006.12]
Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status. [2006.11]
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. [2006.10]
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. [2006.09.01]
Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? [2006.04]
Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine. [2006.01]
Pharmacokinetics of famotidine in infants. [2005]
The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. [2004.01]
Safety and cost of rapid i.v. injection of famotidine in critically ill patients. [1995.09.01]
Effects of intravenous famotidine on gastric acid secretion in patients undergoing cardiac surgery. [1995.04]
Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer. [1995.04]
Hemodynamic effects of intravenous famotidine in patients undergoing cardiac surgery. [1995.01]
Effect of H2-receptor antagonists cimetidine and famotidine on interdigestive gastric motor activity and lower esophageal sphincter pressure in progressive systemic sclerosis. [1994.07]
Assessment of 24-hour gastric pH measurements in trauma patients receiving intravenous famotidine by intermittent bolus versus continuous infusion administration. [1994.07]
Famotidine increases plasma alcohol concentration in healthy subjects. [1994.02]
Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine. [1993.10]
Pharmacokinetics of famotidine in patients with cirrhosis and ascites. [1992]
[Famotidine does not modify the plasma levels of lidocaine for spinal anesthesia. A comparative study of famotidine and cimetidine] [1992]
Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer. [1988.04]
Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers. [1987.11]
Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies. [1987.11]
Well-designed clinical trials possibly related to Pepcid Injection (Famotidine Injection)
A randomized clinical trial of histamine 2 receptor antagonism in
treatment-resistant schizophrenia. [2013]
Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy. [2010.11.14]
[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients] [2010.04]
Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study. [2010.04]
[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients]. [2010.04]
Stress ulcer, gastritis, and gastrointestinal bleeding prophylaxis in critically ill pediatric patients: a systematic review. [2010.01]
[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese
patients]. [Article in Japanese] [2010]
Effectiveness of medications used to attenuate antipsychotic-related weight gain
and metabolic abnormalities: a systematic review and meta-analysis. [2010]
Novel and emerging treatments for autism spectrum disorders: a systematic review. [2009.10]
Stress ulcer, gastritis, and gastrointestinal bleeding prophylaxis in critically ill pediatric patients: A systematic review* [2009.09.15]
Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects. [2009.06]
Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. [2009]
Triple antimicrobial therapy and acid suppression in dogs with chronic vomiting and gastric Helicobacter spp. [2007.11]
Use of histamine2-antagonists for the treatment of verruca vulgaris. [2007.07]
Use of Histamine2-Antagonists for the Treatment of Verruca Vulgaris (July/August). [2007.05.29]
No significant difference in neutrophil activation found among three H2RAs. [2007.02]
Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial. [2006.12]
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. [2006.10.03]
Oral sodium citrate increases nausea amongst elective Cesarean delivery patients. [2006.08]
[Effects of oral clonidine premedication on the heart rate response to intravenous atropine during propofol anesthesia] [2005.09]
Intramuscular tramadol increases gastric pH during anesthesia. [2004.06]
Clonidine premedication reduces maternal requirement for intravenous morphine after cesarean delivery without affecting newborn's outcome. [2001.09]
Propofol anesthesia enhances pressor response to ephedrine in patients given clonidine. [1999.07]
Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease. [1998.01]
Effects of clonidine premedication on the pressor response to alpha-adrenergic agonists. [1995.11]
Diuretic effect of clonidine during isoflurane, nitrous oxide, and oxygen anesthesia. [1994.10]
In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). [1993.07.23]
Day-night and individual differences in response to constant-rate ranitidine infusion. [1991.02]
Other research related to Pepcid Injection (Famotidine Injection)
Famotidine as a radioprotector for rectal mucosa in prostate cancer patients
treated with radiotherapy: phase I/II randomized placebo-controlled trial. [2014]
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole,
pantoprazole, and famotidine: a prospective, randomized, crossover study. [2013]
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: A double-blind, randomized trial. [2011.11]
Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer. [2011.02]
Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists. [2011.02]
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a
double-blind, randomized trial. [2011]
Comparison of the efficacy of irsogladine maleate and famotidine for the healing
of gastric ulcers after Helicobacter pylori eradication therapy: a randomized,
controlled, prospective study. [2011]
Preventive effects of lansoprazole and famotidine on gastric mucosal injury
induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. [2011]
Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. [2010.10]
Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. [2010.09.15]
Preventive Effects of Lansoprazole and Famotidine on Gastric Mucosal Injury Induced by Low-Dose Aspirin in Helicobacter pylori-Negative Healthy Volunteers. [2010.07.27]
A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis. [2010.07.15]
Preparation and evaluation of famotidine polymorphs. [2010.06.01]
Pulse infusion interleukin-2 with famotidine and cyclophosphamide has activity in previously treated metastatic melanoma. [2010.04]
Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach. [2010.01.01]
Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach. [2010.01]
A case of famotidine-induced anaphylaxis. [2010]
Efficacy of omeprazole versus high-dose famotidine for prevention of
exercise-induced gastritis in racing Alaskan sled dogs. [2010]
Famotidine is inferior to pantoprazole in preventing recurrence of
aspirin-related peptic ulcers or erosions. [2010]
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. [2009.10.15]
Are proton pump inhibitors really superior to famotidine in Japanese ulcer patients? [2009.07]
High-dose intensity pulse interleukin-2 with famotidine in metastatic kidney cancer. [2009.04]
Famotidine orally disintegrating tablets: bitterness comparison of original and generic products. [2009.04]
Effects of combination treatment with famotidine and methylmethionine sulfonium chloride on the mucus barrier of rat gastric mucosa. [2009.03]
Activity of continuous infusion + pulse interleukin-2 with famotidine in metastatic melanoma. [2009.02]
Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug. [2009.01]
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis. [2009]
Intravenous famotidine does not always change core temperature during general anesthesia. [2009]
Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study. [2009]
Effects of mepyramine and famotidine on the physostigmine-induced antinociception in the formalin test in rats. [2008.11.15]
Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine. [2008.11]
High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. [2008.10]
[Efficacy and safety of famotidine for the treatment of stress ulcers in neonates] [2008.10]
Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. [2008.08]
Prevention of Indomethacin-Induced Gastric Mucosal Injury in Helicobacter pylori-Negative Healthy Volunteers: A Comparison Study Rebamipide vs Famotidine. [2008.07]
Famotidine polymorphic transformation in the grinding process significantly depends on environmental humidity or water content. [2008.06.05]
The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption. [2008.05]
Formulation design of taste-masked particles, including famotidine, for an oral fast-disintegrating dosage form. [2008.04]
Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation. [2008.03]
|